3 Things You Need to Know If You Buy Novavax Today [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
in the coronavirus vaccine race, sending the stock to a 2,700% gain back in 2020. But when Novavax fell behind on the road to commercialization, the shares declined -- and even the eventual regulatory approval and market entry of that vaccine didn't much help. In recent times, though, Novavax has taken steps to improve its profitability prospects. And in the wake of big news earlier this month, the shares surged again, giving investors hope that the company may be just at the beginning of a period of positive momentum. Is it time to buy? Before making any decisions, here are three things you need to know. 1. Novavax's new partnership may supercharge its revenue growth, but don't expect pandemic-level sales Novavax's vaccine didn't enter the market until after the inoculations developed by Moderna and Pfizer had already taken dominant market shares. This meant it missed out on the biggest revenue opportunity , and it had difficulty competing with these established leaders. But
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine [Yahoo! Finance]Yahoo! Finance
- Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 VaccinePR Newswire
- Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at Bank of America Co. from $12.00 to $18.00. They now have a "neutral" rating on the stock.MarketBeat
- Bull Market and Beyond: 3 Stocks Just Waiting to Soar [Yahoo! Finance]Yahoo! Finance
- Novavax, Inc. (NASDAQ:NVAX) has caught the attention of institutional investors who hold a sizeable 49% stake [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/28/24 - Miss
NVAX
Analyst Actions
- 5/13/24 - HC Wainwright
NVAX
Sec Filings
- 6/14/24 - Form 4
- 6/14/24 - Form 4
- 6/14/24 - Form 4
- NVAX's page on the SEC website